and disappointing take-up of newer long-acting insulin product Toujeo. Zynquista – partnered with Lexicon Pharma – is one of the few candidates coming through the pipeline to make up the ...

Sanofi says Toujeo offers a similar blood glucose reduction to Lantus, with the added bonus of fewer cases of confirmed hypoglycaemia in patients at night – however this benefit was only ...